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Abstract: The neuromuscular junction (NMJ) appears to be a site of pathology in a number of
peripheral nerve diseases. Charcot-Marie-Tooth (CMT) 4C is an autosomal recessive, early onset,
demyelinating neuropathy. Numerous mutations in the SH3TC2 gene have been shown to underlie
the condition often associated with scoliosis, foot deformities, and reduced nerve conduction velocities.
Mice with exon 1 of the Sh3tc2 gene knocked out demonstrate many of the features seen in patients.
To determine if NMJ pathology is contributory to the pathomechanisms of CMT4C we examined
NMJs in the gastrocnemius muscle of SH3TC2-deficient mice. In addition, we performed proteomic
assessment of the sciatic nerve to identify protein factors contributing to the NMJ alterations and the
survival of demyelinated axons. Morphological and gene expression analysis of NMJs revealed a lack
of continuity between the pre- and post-synaptic apparatus, increases in post-synaptic fragmentation
and dispersal, and an increase in expression of the gamma subunit of the acetylcholine receptor.
There were no changes in axonal width or the number of axonal inputs to the NMJ. Proteome
investigations of the sciatic nerve revealed altered expression of extracellular matrix proteins important
for NMJ integrity. Together these observations suggest that CMT4C pathology includes a compromised
NMJ even in the absence of changes to the innervating axon.
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1. Introduction
Charcot-Marie Tooth (CMT) disease was first reported over a hundred years ago [1]. Research in
a well-defined Norwegian population demonstrated a prevalence of 1/2500 [2] suggesting it is one
of the most frequent forms of inherited neurological disorders [3]. Several genetic defects have been
linked to the demyelinating forms of the disease [3–7], which can be dominant (CMT1) or recessive
(CMT4). CMT subtype 4C (CMT4C) is an autosomal recessive form of demyelinating neuropathy
usually with an early onset [3,7,8]. The clinical hallmarks comprise distal muscular atrophy, scoliosis,
distal weakness, foot deformities (pes cavus), and reduced motor and sensory nerve conduction
velocities [3–5,9,10]. However, the age of onset and disease severity may change within and between
families, thus making genotype–phenotype correlations difficult. The disease locus for CMT4C is
on chromosome 5q23-33 [4,5], and both nonsense and missense mutations in the SH3TC2/KIAA1985
gene have been shown to be causative for CMT4C [3,4,6]. Over 70 causative mutations for CMT4C
have been described with the R954X mutation shown to be particularly common [3,7]. Expression of
SH3TC2 has recently been described in in cultured Schwann cells [11]. It is a well conserved 144 kDa
protein containing Scr homology 3 (SH3) and tetratricopeptide repeat (TRP) domains, suggesting a
role as scaffold protein [6,12]. Its role in myelination is supported by its localisation to the plasma
membrane and to the perinuclear endocytic recycling compartment [8,12–14].
The Sh3tc2 knock out mouse (Sh3tc2∆Ex1/∆Ex1) [8] was created to better understand the
pathophysiology of CMT4C. These mice show development, life-span, and fertility similar to those
of wild type and heterozygous littermates and while they do not develop scoliosis, they do harbour
peripheral nervous system abnormalities. At 4 weeks of age the homozygous animals’ manifest
typical features of neuropathy such as reduction of motor nerve conduction velocity and sensory nerve
conduction velocity, thus suggesting a possible impairment of fiber myelination. At six months of age
they have an abnormal clenching of toes and clasping of hindlimbs upon tail suspension. Electron (EM)
and light microscopy of the sciatic nerve shows hypomyelination, changes at nodes of Ranvier, and in
older mice occasional onion bulb formation and abnormal Schwann cell branches [8]. The resulting
abnormal organization of the nodes of Ranvier found both in Sh3tc2∆Ex1/∆Ex1 mice and in CMT4C
patients, seems to support the role of SH3TC2 in myelination.
Notably, it has been shown that SH3TC2 interacts with the guanosine triphosphatase Rab11,
which is known to be involved in the recycling of internalised membranes and receptors back to the
cell surface [8,13]. In this scenario, SH3TC2 acts as a Rab11 effector molecule, suggesting that SH3TC2
mutations lead to a disruption of this interaction resulting in myelination impairment [13,14]. In the
peripheral nervous system, the Neuregulin-1/ErbB signalling pathway is important for myelination
during early post-natal development. SH3TC2 acts as a regulator of ErbB2 receptor internalisation
that is required for myelination and mutations in this gene have been demonstrated to prevent its
promotion of internalisation [15]. Taken together, the evidence suggest an important role of endosomal
recycling process in myelin sheath formation as myelination requires dramatic changes in the cellular
architecture of differentiating glia and a high degree of cell polarization [16].
Morphological findings obtained from EM analysis done on human sural nerve biopsies from
patients with CMT4C, show non-myelinating Schwann cell complexes with abnormal cell processes,
demyelinated-remyelinated axons surrounded by onion bulbs made up of empty basal lamina sheaths,
and Remak bundles [3,5,10].
There is currently no treatment for CMT4C patients and existing approaches rely on trying
to reduce symptoms through orthopaedic surgery, special shoes for ankle support, and physical
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exercise [3,17]. Affected individuals are overseen by several different specialists including neurologists,
physiotherapists and orthopaedists [17].
Paramount to finding potential therapies for CMT4C is the understanding of the exact mechanisms
of pathogenesis of the disease.
The neuromuscular junction (NMJ) has recently been shown to be dysfunctional in many
conditions which do not necessarily have the NMJ as a primary site of pathogenesis [18–20]. NMJ
dysfunction, structural changes, and delayed maturation have also been observed in animal models of
CMT1A [21,22], and CMT2D [23,24]. Treatments for some causes of NMJ dysfunction are available [25],
and thus the NMJ could represent a therapeutic target for some of these conditions, as has been shown
in a mouse model of CMT2D [24]. In a number of the above conditions Schwann cells, specifically
Terminal Schwann cells (tSC) at the NMJ, have been hypothesised to contribute to the observed
pathology [26]. Given the expression of SH3TC2 in Schwann cells, and the importance of tSC for NMJ
maintenance and recovery, we hypothesised that NMJ dysfunction could contribute to the pathology
observed in CMT4C. We examined this possibility using the Sh3tc2∆Ex1/∆Ex1 mouse model, which was
previously shown to be a useful in vivo model to study the disease mechanisms of CMT4C [8].
2. Results
To determine if NMJ dysfunction may be a significant contributing factor to the pathomechanisms
of CMT4C we examined tissue taken from Sh3tc2∆Ex1/∆Ex1 mice and compared it to that from control
animals (heterozygous Sh3tc2∆Ex1/+ mice). This included structural and transcriptional analysis of the
NMJ and proteomic investigations of the sciatic nerve. The Sh3tc2∆Ex1/+ mice have been previously
described [8,15] and show a mild phenotype, which includes normal development, lifespan, and
fertility. However, on suspension they demonstrate an abnormal clenching of the hindlimbs (Figure 1)
and they also have reduced nerve conduction velocities [8].
In . J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  3 of 22 
 
[25], and thus the NMJ could represent a therapeutic target for some of these conditions, as has been 
shown in a mouse model of CMT2D [24]. In a number of the above conditions Schwann cells, 
specifically Terminal Schwann cells (tSC) at the NMJ, have been hypothesised to contribute to the 
observed pathology [26]. Given the expression of SH3TC2 in Schwann cells, and the importance of 
tSC for NMJ maintenance and recovery, we hypothesised that NMJ dysfunction c ld contribute to 
the pathology observed in CMT4C. We examined this possibility using the Sh3tc2ΔEx1/ΔEx1 mouse 
model, which was previously shown to be a useful in vivo model to study the disease mechanisms 
of CMT4C [8]. 
2. R sults 
To determine if NMJ dysfunction may be a significant contributing factor to the 
pathomechanisms of CMT4C we examined tissue tak n from Sh3tc2ΔEx1/ΔEx1 mice and c mpared it to 
that from control animals (heterozygous Sh3tc2ΔEx1/+ mice). This included structural and 
transcriptional analysis of the NMJ and proteomic investigations of the sciatic nerve. The Sh3tc2ΔEx1/+ 
mice have been previously described [8,15] and show a mild phenotype, which includes normal 
development, lifespan, and fertility. However, on suspension they demonstrate an abnormal 
clenching of the hindlimbs (Figure 1) and they also have reduced nerve conduction velocities [8]. 
 
Figure 1. Hindlimb abnormalities in Sh3tc2ΔEx1/ΔEx1 mice. Suspension of mice by their tails shows 
normal positioning of the limbs and toes in control animals (A) and abnormal clenching of the toes in 
Sh3tc2ΔEx1/ΔEx1 mice (B). 
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NMJ labelling was performed in gastrocnemius muscle from eight-month healthy control and 
affected Sh3tc2ΔEx1/ΔEx1 mice. The labelling was performed on whole mount muscle using 
neurofilament to label the nerve, synaptophysin to indicate the pre-synaptic terminal and α-
bungarotoxin to identify the post-synaptic endplate. Analysis was performed blinded to the animal 
group and used a standardised methodology, “NMJ-morph”, which consists of a series of 
morphometric analysis comprising measurements of the nerve, pre-/post-synapses and their 
structural alignment [27]. In addition to the variables calculated using NMJ-morph, we also recorded 
the number of NMJs in which no pre-synaptic structure (synaptophysin or neurofilament staining) 
was observed, despite a post-synaptic endplate (α-bungarotoxin) being visible, these are sometimes 
referred to as “vacant” or “denervated” NMJs [19,21]. The following data is presented as mean ± SEM 
with data for control animals being given first. 
Analysis of the degree of overlap revealed a lack of alignment between the pre- and post-
synaptic apparatus in Sh3tc2ΔEx1/ΔEx1 animals. With Sh3tc2ΔEx1/ΔEx1 mice having a significantly smaller 
area of synaptic contact (control 177.4 ± 7.665 μm2 vs Sh3tc2ΔEx1/ΔEx1 148.4 ± 8.248 μm2 (mean ± SEM)) 
(Figure 2A). This resulted in a significantly reduced “overlap” percentage in the Sh3tc2ΔEx1/ΔEx mice 
(67.69 ± 1.481% vs 57.81 ± 1.649%) (Figure 2B,C). While there was an increase in the percentage of 
NMJs that were “vacant” (absent neurofilament and synaptophysin staining), in the Sh3tc2ΔEx1/ΔEx1 
mice, this was not significant (Figure 2D). There was an increase in the degree of fragmentation in 
Figure 1. Hindlimb abnormalities n Sh3tc2∆Ex1/∆Ex1 mice. Suspe sion of mice by their tail shows
normal positioning of the limbs and toes in control a i als (A) and abnormal clenching of the toes in
Sh3tc2∆Ex1/∆Ex1 mice (B).
2.1. NMJ Structural Changes in Sh3tc2∆Ex1/∆Ex1 Mice
NMJ labelling was performed in gastrocnemius muscle from eight-month healthy control
and affected Sh3tc2∆Ex1/∆Ex1 mice. The labelling was performed on whole mount muscle
using ne rofilament to label the nerve, synaptophysin to indicate the pre-synaptic ter inal and
α-bungar toxin to id ntify he post-synaptic endplate. Analysis was performed blinded to the animal
group and used a standardised methodology, “NMJ-morph”, which consists of a series of morphometric
analysis comprising measurements of the nerve, pre-/post-synapses and their structural alignment [27].
In addition to the variables calculated using NMJ-morph, we also recorded the number of NMJs in
which no pre-synaptic structure (synaptophysin or neurofilament staining) was observed, despite a
post-synaptic endplate (α-bungarotoxin) being visible, these are sometimes referred to as “vacant” or
“denervated” NMJs [19,21]. The following data is presented as mean ± SEM with data for control
animals being given first.
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Analysis of the degree of overlap revealed a lack of alignment between the pre- and post-synaptic
apparatus in Sh3tc2∆Ex1/∆Ex1 animals. With Sh3tc2∆Ex1/∆Ex1 mice having a significantly smaller area
of synaptic contact (control 177.4 ± 7.665 µm2 vs. Sh3tc2∆Ex1/∆Ex1 148.4 ± 8.248 µm2 (mean ± SEM))
(Figure 2A). This resulted in a significantly reduced “overlap” percentage in the Sh3tc2∆Ex1/∆Ex mice
(67.69± 1.481% vs. 57.81± 1.649%) (Figure 2B,C). While there was an increase in the percentage of NMJs
that were “vacant” (absent neurofilament and synaptophysin staining), in the Sh3tc2∆Ex1/∆Ex1 mice, this
was not significant (Figure 2D). There was an increase in the degree of fragmentation in Sh3tc2∆Ex1/∆Ex
mice (0.1415 ± 0.0219 vs. 0.2784 ± 0.02916) (Figure 2E), determined by dividing 1 by the number of
fragments; the increase in fragmentation also contributed to the significant reduction in the average area
of acetylcholine receptor (AChR) clusters (222.4 ± 10.67 µm2 vs. 171.4 ± 10.42 µm2) (Figure 2F,G).Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  5 of 22 
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of Sh3tc2∆Ex1/∆Ex1 (n = 3) mice compared to control (n = 3) animals. (A) The area of synaptic contact
between the pre- and post-synaptic apparatus is reduced in the NMJs of Sh3tc2∆Ex1/∆Ex1 mice (NMJs
n = 91) when compared to control mice (NMJs n = 115) (Mann-Whitney test); (B) In addition, the
percentage overlap, defined as the extent to which the nerve terminal overlaps the AChRs, was
reduced in Sh3tc2∆Ex1/∆Ex1 mice (NMJs n = 115) when compared to control animals (NMJs n = 91)
(Mann-Whitney test); (C) Reduced overlap in Sh3tc2∆Ex1/∆Ex1 animals. Control images show an NMJ
with 75% overlap, Sh3tc2∆Ex1/∆Ex1 images show 50% (*) and 28% (#) overlap. NF = Neurofilament,
Syn = synaptophysin; (D) The number of “vacant” NMJs, defined as an endplate with no pre-synaptic
staining present, was not increased in the Sh3tc2∆Ex1/∆Ex1 animals (n = 3) compared to control animals
(n = 3) (unpaired t-test); (E) The fragmentation index, the number of discrete AChR clusters present
at the endplate, was increased in Sh3tc2∆Ex1/∆Ex1 (NMJs n = 114) vs. control (NMJs n = 132) animals
(Mann-Whitney test); (F) There was a concomitant decrease in average size of AChR clusters in
Sh3tc2∆Ex1/∆Ex1 (NMJs n = 114) vs. control (NMJs n = 133) NMJs (Mann-Whitney test). (G) Images
showing increased fragmentation, reduced average size of AChR clusters, and some dispersal of the
endplate. Graphs show mean ± SEM, scale bar is 25 µm, * p < 0.05, *** p < 0.0005, **** p < 0.0001.
Following the observation of changes in alignment of the pre- and post-synaptic apparatus, we
examined pre- and post-synaptic structures in more detail. There was a slight but non-significant
increase in the AChR perimeter of Sh3tc2∆Ex1/∆Ex1 animals (Figure 3A) which could be attributed to the
increase in fragmentation seen above. There were no differences between control and Sh3tc2∆Ex1/∆Ex1
animals in terms of AChR area (Figure 3B), or the endplate region, which encompasses all the AChRs
and the space between those receptors (Figure 3B–E). However, the compactness of the endplate,
determined by dividing the AChR area by the endplate area was found to be significantly reduced in
the Sh3tc2∆Ex1/∆Ex1 animals (Figure 3E,F) (52.18 ± 0.9829% vs. 49.15 ± 1.077%), suggesting there was
dispersal of the endplate (Figure 2G).
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diameter (Mann-Whitney test); (D) Endplate perimeter (Mann-Whitney test) and; (E) Endplate area 
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In terms of pre-synaptic changes there were no significant differences in nerve terminal 
perimeter or area between control and Sh3tc2ΔEx1/ΔEx1 mice (Figure 4A,B). However, there was a 
Figure 3. Post-synaptic changes at the endplate of Sh3tc2∆Ex1/∆Ex1 (n = 3) versus control (n = 3) mice:
there were ifferences between Sh3tc2∆Ex1/∆Ex1 (NMJ n = 114) and control mice (NMJ n = 133) in
terms of (A) AChR perimeter (Man -Whitney test); (B) AChR area (Mann-Whitney test); (C) Endplate
diameter (Mann- hitney test); (D) Endplate perimeter (Mann-Whitney test) and; (E) Endplate area
(Mann-Whitney test); (F) There was a slight but significant reduction in the compactness of the NMJs
in Sh3tc2∆Ex1/∆Ex1 animals (unpaired t-test). Graphs show mean ± SEM, * p < 0.05.
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In terms of pre-synaptic changes there were no significant differences in nerve terminal perimeter or
area between control and Sh3tc2∆Ex1/∆Ex1 mice (Figure 4A,B). However, there was a significant increase
in the number of terminal branches (48.67 ± 3.884 vs. 80.9 ± 8.513) and therefore not surprisingly
branch points (29.78 ± 2.436 vs. 47.62 ± 5.922) (Figure 4C,D). While this increase in branching gave a
significant increase in total length of branches (78.61 ± 4.641 µm vs. 107.4 ± 9.222 µm) (Figure 4E), the
average length of these branches was significantly reduced (2.094.4 ± 0.1009 µm vs. 1.645 ± 0.08686 µm)
(Figure 4F). The increase in branching of the Sh3tc2∆Ex1/∆Ex1 mice as seen in the increase in branching and
branchpoints contributed to a significant increase (4.688 ± 0.08565 vs. 5.189 ± 0.1016) in the complexity
of their NMJs (Figure 4G,H).
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Figure 4. Pre-synaptic changes at the NMJs of Sh3tc2∆Ex1/∆Ex1 (n = 3) compared to control (n = 3)
mice. There were no changes in the Sh3tc2∆Ex1/∆Ex1 animals (NMJ n = 91) c mpa ed to control (NMJ
n = 118) in t rms of: (A) Nerv terminal perimeter (Man -Whitney test) or; (B) Nerve terminal area
(Mann-Whitney test); (C) The number of terminal branches was increased in Sh3tc2∆Ex1/∆Ex1 animals
(NMJ n = 91) compared to control (NMJ n = 117) mice (Mann-Whitney test); (D) This is also reflected in
the increase in branching points in Sh3tc2∆Ex1/∆Ex1 animals compared to control mice (Mann-Whitney
test); (E) The total length of all branches was increased in the Sh3tc2∆Ex1/∆Ex1 animals compared to
control animals while the average length of these branches was reduced (Mann-Whitney test) (F).
The complexity of the NMJs was increased in Sh3tc2∆Ex1/∆Ex1 animals (Mann-Whitney test) (G). (H) In
the Sh3tc2∆Ex1/∆Ex1 animals, many small projections can be seen, but the length of these projections is
not long ( eurofilament & Syn = Syna tophysin). Graphs show mean ± SEM, scale bar is 25 µm,
** p <0. 05, *** p < 0.
Interestingly there was an bsence of axonal changes, with the number of axonal in t axon
width not being significantly different between control and Sh3tc2∆Ex1/∆Ex1 igure 5A–C).
The above analysis revealed a reduction in the compactness of the post-synaptic endplate,
increased post-synaptic fragmentation, increased branching of the pre-synaptic terminal, and a
reduction in the degree of overlap of the pre- and post-synaptic apparatus. Taken together this
demonstrates a clear alteration of the NMJ structure independent of axonal changes (no reduction in
axon width). To explain these structural changes at the NMJ of Sh3tc2∆Ex1/∆Ex1 mice, we examined
RNA transcripts of genes of interest in NMJ plasticity. Whereas skeletal muscle of 8 months old animals
was investigated to identify perturbations of NMJ-architecture, qPCR-studies were performed on
muscle samples derived from 6 months old animals. This approach aimed to identify factors altered at
an earlier time-point that we hypothesize to contribute to the NMJ structural changes.
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were identified with neurofilament staining and the diameter determined by measuring the axon at 
its widest (*) and thinnest (#) points, and where the axon ramifies ($). Graphs are mean ± SEM, scale 
bar is 25 μm. 
The above analysis revealed a reduction in the compactness of the post-synaptic endplate, 
increased post-synaptic fragmentation, increased branching of the pre-synaptic terminal, and a 
reduction in the degree of overlap of the pre- and post-synaptic apparatus. Taken together this 
demonstrates a clear alteration of the NMJ structure independent of axonal changes (no reduction in 
axon width). To explain these structural changes at the NMJ of Sh3tc2ΔEx1/ΔEx1 mice, we examined RNA 
transcripts of genes of interest in NMJ plasticity. Whereas skeletal muscle of 8 months old animals 
was investigated to identify perturbations of NMJ-architecture, qPCR-studies were performed on 
muscle samples derived from 6 months old animals. This approach aimed to identify factors altered 
at an earlier time-point that we hypothesize to contribute to the NMJ structural changes. 
2.2. Gene Expression Analysis of Denervation and Reinnervation Markers 
Gene expression analysis of denervation and reinnervation markers, performed by qPCR on 
gastrocnemius muscle from Sh3tc2ΔEx1/ΔEx1 mice, revealed the presence of significant variations. The 
AChRγ subunit, often increased in adult cases of denervation, was significantly increased (Figure 6A) 
in Sh3tc2ΔEx1/ΔEx1 mice (1.003 ± 0.1887 vs 5.943 ± 1.161). The Sh3tc2ΔEx1/ΔEx1 mice group had one result 
removed as an outlier (determined using the ROUT method, GraphPad Prism), however, this value 
was a 236-fold increase on the control animals and thus its removal does not alter the pattern of 
increased AChRγ seen in the Sh3tc2ΔEx1/ΔEx1 mice. The remaining denervation markers (AChRα, AChRε, 
Muscle-Specific Kinase (MuSK)), and Neural cell adhesion molecule (NCam)) did not show any significant 
variations. In terms of markers of NMJ reinnervation, Nerve growth factor (NGF) was significantly 
upregulated (1 ± 0.1436 vs 1.685 ± 0.1243) in Sh3tc2ΔEx1/ΔEx1 mice. While several other gene transcripts 
Figure 5. Axonal parameters in Sh3tc2∆Ex1/∆Ex1 (n = 3) and control (n = 3) animals: (A) Only single
axonal inputs were observed for both Sh3tc2∆Ex1/∆Ex1 (NMJs n= 15) and control (n = 22) animals,
therefore no SEM is given; (B) There were no differences in the axon diameter (unpaired t-test). (C) Axon
inputs were identified with neurofilament staining and the diameter determined by measuring the
axon at its widest (*) a d thinnest (#) points, and where the axon ramifies ($). Graphs are mean ± SEM,
scale bar is 25 µm.
2.2. Gene Expression Analysis of Denervation and Reinnervation Markers
Gene expression analysis of denervation and reinnervation markers, performed by qPCR on
gastrocnemius muscle from Sh3tc2∆Ex1/∆Ex1 mice, revealed the presence of significant variations.
The AChRγ subunit, often increased in adult cases of denervation, was significantly increased
(Figure 6A) in Sh3tc2∆Ex1/∆Ex1 mice (1.003 ± 0.1887 vs. 5.943 ± 1.161). The Sh3tc2∆Ex1/∆Ex1 mice
group had one result removed as an outlier (determined using the ROUT method, GraphPad Prism),
however, this value was a 236-fold increase on the control animals and thus its removal does not alter
the pattern of increased AChRγ seen in the Sh3tc2∆Ex1/∆Ex1 mice. The remaining denervation markers
(AChRα, AChRε, Muscle-Specific Kinase (MuSK)), and Neural cell adhesion molecule (NCam)) did not show
any significant variations. In terms of markers of NMJ reinnervation, Nerve growth factor (NGF) was
significantly upregulated (1 ± 0.1436 vs. 1.685 ± 0.1243) in Sh3tc2∆Ex1/∆Ex1 mice. While several other
gene transcripts were increased, there was considerable variation in the samples, and no significant
differences were seen in brain-derived neurotrophic factor (BDNF), cilliary neurotrophic factor (CNTF), glial
cell derived neurotrophic factor (GDNF), neurotrophic receptor tyrosine kinase 2 and 3 (NTRK2 & 3), and p75
(Figure 6B).
While morphological analysis revealed structural changes at the NMJ, the above results also
indicated there is a certain amount of denervation occurring in the animals, an interesting finding
given the absence of axonal changes. However, the denervation may be compensated by the increased
expression of NGF as an attempt to restore a functional innervation. Accordingly, the molecular
findings appear to support the morphological alterations seen through the confocal microscopy
analysis of the NMJs. To further explain the changes we saw at the NMJ and in particular the absence
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of changes in the axon width and number of axonal inputs, we investigated the proteomic signature of
sciatic nerves derived from eight-month-old Sh3tc2∆Ex1/∆Ex1 animals, filtering for proteins relevant to
NMJ-function and integrity.
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mice. QPCR analysis of; (A) Denervation markers: AChRα, AChRε, AChRγ, MuSK and NCam and of
reinnervation markers: BDNF, NGF, CNTF, GDNF, NTRK2, NTRK3, p75 in gastrocnemius muscle of
6 months old control and Sh3tc2∆Ex1/∆Ex1 mice (unpaired t-test) (B). Values for Sh3tc2∆Ex1/∆Ex1 animals
were normalized to control animals, dashed line = 1 (control animals). Graphs are mean ± SEM,
* p < 0.05, ** p < 0.005.
2.3. Relevant Findings in the Proteomic Signature of SH3TC2-deficient Nerves from Sh3tc2∆Ex1/∆Ex1 Animals
We expected the pre-synaptic NMJ structural changes we observed in Sh3tc2∆Ex1/∆Ex1 animals to
be accompanied by axonal changes that contributed to this disruption, as previously reported [21,23,24].
Howev r, the number of axon l inputs and axonal width were unchanged in Sh3tc2∆Ex1/∆Ex1 animals,
furthe more, pre-synaptic changes t at increased the complexity of the terminal o curred. While
t anscriptional analysis suggested that these observations could be attributed to an inc ease in
neurotrophins ident fied by the study of gastrocnemius muscle, the NMJ is a tightly cont lled functional
unit that is responsive to signaling from both pre and post-synaptic tissues. We the efore wanted to
examine both the possible mediators of the observed NMJ alterations earlier in the motor control
pathway and proteins preventing the preservation of axon diameter upon demyelination. Applied
proteomics represents a very powerful tool to obtain unbiased insights into the pathophysiology of
diseas s such as neuromuscular disorders [28]. Her , made use of this technique to gain further
molecul r insights into NMJ-pathology as well as prevention of axonal deg neration. Doing so, our
filtered data reveal d changes of 20 relevant proteins out of a total of 40 alt red in abundance (50%)
in the sciatic nerves of Sh3tc2∆Ex1/∆Ex1 mice. These proteins were selected according to their known
functions and thus feasible impact in axonal preservation as well as NMJ-vulnerability and are presented
in Table 1. All information about these proteins was extracted from uniprot (www.uniprot.org, accessed
on 9 October 2018). Interestingly most of the proteins that were elevated in the Sh3tc2∆Ex1/∆Ex1 animals
are associated with the extra-cellular matrix (ECM).
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Table 1. List of relevant proteins and their subcellular localizations and functions identified with
altered abundances in sciatic nerves from eight-month old Sh3tc2∆Ex1/∆Ex1 mice. All listed proteins
have been quantified based on at least one unique peptide. ECM: extra-cellular matrix.
Accession # Protein Name UniquePeptides
Fold of
Regulation
(Log2)
p-ANOVA Localization Function
Q8BGY2
Eukaryotic translation
initiation factor 5A-2
(IF5A2_MOUSE)
2 −2.45 0.001 Nucleus/ ER
Mediates effects of polyamines on
neuronal process extension and
survival
Q62264
Thyroid
hormone-inducible
hepatic protein
(THRSP_MOUSE)
1 −2.36 0.048 Nucleus
Mediates biosynthesis of
triglycerides with medium-length
fatty acid chains and modulates
transcription factor activity of
THRB
Q8K0E8 Fibrinogen beta chain(FIBB_MOUSE) 24 2.06 0.006 ECM
Polymerizes to form an insoluble
fibrin matrix
P03995
Glial fibrillary acidic
protein
(GFAP_MOUSE)
5 2.08 0.009 Cytoplasm
Class-III intermediate filament;
cell-specific marker that, during
the development of the central
nervous system, distinguishes
astrocytes from other glial cells
Q8BK62
Olfactomedin-like
protein 3
(OLFL3_MOUSE)
4 2.14 <0.0005 ECM
Critical for early development and
functional organization of the
nervous system as well as
hematopoiesis
Q60847
Collagen alpha-1(XII)
chain
(COCA1_MOUSE)
51 2.16 <0.0005 ECM
In general, collagens have been
described to be important for the
structural and functional integrity
of the neuromuscular junction
P21981
Protein-glutamine
gamma-
glutamyltransferase 2
(TGM2_MOUSE)
12 2.17 <0.0005 Multiple
Catalyzes the cross-linking of
proteins and the conjugation of
polyamines to proteins
P14106
Complement C1q
subcomponent
subunit B
(C1QB_MOUSE)
1 2.21 0.047 ECM First component of the serumcomplement system
P08121
Collagen alpha-1(III)
chain
(CO3A1_MOUSE)
3 2.42 0.042 ECM
In general, collagens have been
described to be important for the
structural and functional integrity
of the neuromuscular junction
Q8VCM7 Fibrinogen gammachain (FIBG_MOUSE) 20 2.47 0.004 ECM
Polymerizes to form an insoluble
fibrin matrix
Q61001
Laminin subunit
alpha-5
(LAMA5_MOUSE)
24 2.50 0.020 ECM
Mediate the attachment, migration
and organization of cells into
tissues during embryonic
development by interacting with
other extracellular matrix
components
P55002
Microfibrillar-associated
protein 2
(MFAP2_MOUSE)
3 2.78 0.050 ECM Fibrinogen binding; component ofthe elastin-associated microfibrils
P51910 Apolipoprotein D(APOD_MOUSE) 9 2.92 <0.0005 ECM
Glia-derived apolipoprotein
required for peripheral nerve
functional integrity and a timely
response to injury
Q8CC35 Synaptopodin(SYNPO_MOUSE) 1 3.02 0.005 Cytoskeleton
modulating actin-based shape and
motility of dendritic spines;
involved in synaptic plasticity
P11087
Collagen alpha-1(I)
chain
(CO1A1_MOUSE)
8 3.08 0.036 ECM
In general, collagens have been
described to be important for the
structural and functional integrity
of the neuromuscular junction
P22935
Cellular retinoic
acid-binding protein 2
(RABP2_MOUSE
2 3.14 <0.0005 Nucleus/ ER Participates in retinoicacid-modulated nerve regeneration
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Table 1. Cont.
Accession # Protein Name UniquePeptides
Fold of
Regulation
(Log2)
p-ANOVA Localization Function
Q01149
Collagen alpha-2(I)
chain
(CO1A2_MOUSE)
7 3.32 0.033 ECM
In general, collagens have been
described to be important for the
structural and functional integrity
of the neuromuscular junction
O08746 Matrilin-2(MATN2_MOUSE) 11 3.40 0.003 ECM
Involved in matrix assembly and
axon guidance
P08226 Apolipoprotein E(APOE_MOUSE) 18 3.52 <0.0005 ECM
Regulation of regeneration in the
peripheral nervous system
Q2UY11
Collagen
alpha-1(XXVIII) chain
(COSA1_MOUSE
19 4.10 0.006 ECM
In general, collagens have been
described to be important for the
structural and functional integrity
of the neuromuscular junction
3. Discussion
CMT4C is a demyelinating form of inherited neuropathy, with patients suffering from a
combination of symptoms including muscular atrophy, distal weakness, foot deformities, scoliosis,
and reduced motor and sensory nerve conduction velocities [3,4,9]. Its prevalence is estimated at
0.7/100,000 making it the most common type of recessive CMT [7]. The lack of treatment for CMT4C
suggests that more information on the pathomechanisms of the disease are needed. The objective of
our study therefore was to determine if NMJ changes are present in a mouse model of CMT4C and
consequently could present a novel treatment target for the disease.
The list of neuromuscular diseases that are known to have some involvement of the NMJ, either
as a primary or secondary site of pathogenesis is growing [18,19,21–24,29]. While amyotrophic lateral
sclerosis (ALS) is predominantly characterised by the loss of upper and lower motor neurons, the
SOD1G93A mouse has demonstrated integrity of the NMJ is important in the pathomechanisms of the
condition with NMJ alterations appearing early in the disease course [19]. These abnormal alterations
include a decrease in NMJ complexity, an increase in fragmentation, and a decrease in the overlap of
pre-and post-synaptic apparatus, in addition to axonal changes. While remaining innervated, NMJs
from mice models of spinal bulbar muscular atrophy are fragmented, have a wider synaptic cleft,
and abnormal synaptophysin distribution [18]. A reduction in NMJ density, degree of overlap, AChR
cluster size, and increases in fragmentation have also been reported in mouse models of CMT1A and
2D [21–24]. Our phenomenological analysis demonstrating an increase in endplate fragmentation
and dispersal, increased pre-synaptic branching, and a reduction in the degree of overlap of pre- and
post-synaptic apparatus, suggest CMT4C should now be added to the list of neuropathies that are
accompanied by NMJ alterations. Given the Schwann cell pathology demonstrated in Sh3tc2∆Ex1/∆Ex1
mice [8,15] and the importance of tSC for the NMJ this is not unexpected. Future studies should
investigate this hypothesis through the examination of tSC at the NMJ in these animals to provide
more information on the mechanisms causing these changes. This could be performed through EM,
immunolabeling of tSCs and the NMJ, or even through proteomic investigations following laser
dissection of NMJs from tissue. While the NMJ is a tightly controlled unit, with specialised pre- and
post-synaptic regions required to operate in a coordinated manner, it is pharmacologically accessible
and responsive. Promising results from animal models of neuropathy suggest a concerted effort to
improve NMJ function may alleviate some patient’s symptoms’ [29,30].
NMJ analysis performed on gastrocnemius muscle from eight months-old Sh3tc2∆Ex1/∆Ex1 mice,
revealed interesting and significant changes at the NMJs. The analysis followed a standardised
morphometric protocol (“NMJ-morph”), which evaluates several separate pre- and post-synaptic
variables and derived measurements [27]. The automated and standardised nature of this approach
allows for many NMJs to be investigated, therefore increasing the likelihood of uncovering differences
between groups. In this case, some of the most striking observations were decreases in overlap of the
pre- and post-synaptic apparatus, increases in fragmentation, and a reduction in NMJ compactness in
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Sh3tc2∆Ex1/∆Ex1 animals. We had a slight, though non-significant increase in “vacant” NMJs, which has
been seen previously in mouse models of CMT [21,23]. Although unlike other models, in the current
investigation axonal degradation was not observed [21,23,24]. Although it would be interesting to
examine the axons of Sh3tc2∆Ex1/∆Ex1 animals using EM to see if ultrastructure alterations are present
that are undetectable by confocal microscopy.
While many post-synaptic changes were observed in Sh3tc2∆Ex1/∆Ex1 animals, increases in
post-synaptic dispersal and fragmentation, as previously seen in CMT mouse models [24], a number of
changes were pre-synaptic. Specifically, in Sh3tc2∆Ex1/∆Ex1 animals we observed an increase in terminal
branches, branch points, and total length of branches. However, this growth was accompanied by a
reduction in the average length of these branches suggesting that these “new” branches remained short.
The increased branching observed in Sh3tc2∆Ex1/∆Ex1 animals led to an increase in “complexity” of the
pre-synaptic terminal, but this was not matched by the insertion of new AChRs as can be seen by the
reduction in “overlap”. It is possible that the increase in branching and resultant complexity observed
in the Sh3tc2∆Ex1/∆Ex1 animals was an attempt at adaptation of the NMJ to maintain/prevent the loss
of neuromuscular transmission. While structural changes are not in themselves always indicative of a
decrease in NMJ transmission [31], they have been linked to denervation and NMJ dysfunction [24].
Interestingly, previous research demonstrating NMJ structural abnormalities in CMT animal
models has shown strong muscle location specificity of the NMJ loss, and the resulting muscle fiber
atrophy and motor impairment [21,23]. The prospect that this was linked to myosin heavy chain
(MHC) fiber types has been examined [22,32] but ultimately did not reveal anything. However, the
possibility that different muscles are more or less susceptible to denervation due to their MHC fiber
type proportions has not been extensively investigated. This question could also be examined in
Sh3tc2∆Ex1/∆Ex1 animals though the study of muscles with differing MHC compositions, for example
the soleus versus the extensor digitorium longus. The selective vulnerability of distal muscles to
NMJ loss has also been proposed as a potential explanation behind the muscle susceptibility in these
diseases [33]. The extent and timing of NMJ dysmorphology, has been shown to be specific to the
gene disrupted in the animal model, with the severity of the model correlating with the degree of NMJ
pathology [23,24]. It would be interesting to examine the changes we observed in the Sh3tc2∆Ex1/∆Ex1
mice in terms of distal verses proximal muscles, as well as the timings of these changes to determine if
this dysmorphology is occurring early or late in the disease course or is even a developmental deficit.
To obtain molecular insights into the structural NMJ perturbations in SH3TC2-deficient mice, a
transcript analysis of denervation and reinnervation markers was performed in gastrocnemius muscle
using qPCR. The results obtained from the gene expression analysis of denervation (AChRα, AChRε,
AChRγ, MuSK and NCam) and reinnervation (BDNF, NGF, CNTF, GDNF, NTRK2, NTRK, p75) markers
supported the results of the structural analysis. An increase AChRγ has often been seen in cases of
denervation and NMJ dysfunction, as well as CMT [2,23]. Although we did not observe changes
in CNTF, BDNF, and MuSK, that have previously been observed in cases of surgical denervation
and neurotrypsin overexpression [34,35], suggesting the extent and mode of denervation modulates
the gene expression. While AChRγ was increased in Sh3tc2∆Ex1/∆Ex1 animals, the absence of axonal
changes, mild neuropathic phenotype (abnormal toe clenching and clasping of hindlimbs at 6 months),
and lack of changes in many of the transcriptional markers of denervation, suggests that only a
limited amount of denervation is occurring. We hypothesize that while this limited denervation may
contribute to the alterations at the NMJ it cannot account for the full extent of NMJ changes, which may
be mediated by alterations in the tSCs. Analysis of muscle indicators of denervation and reinnervation,
for example fiber type grouping, grouped fiber atrophy, myosin heavy chain co-expressing fibers, or
the presence of small angular fibers may give a more complete picture to the extent of denervation
occurring in the Sh3tc2∆Ex1/∆Ex1 animals.
Transcript analysis also revealed the potent growth factor NGF was increased, potentially
reflecting the increase in NMJ branching seen in Sh3tc2∆Ex1/∆Ex1 animals. The increased expression
of NGF may be explained as an attempt to restore NMJ function, as neurotrophins are known to
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have important roles in neural development, maintenance, and maturation. Indeed, previous studies
have demonstrated that they are present at the NMJ and play a central role in promoting motor axon
sprouting and innervation in response to denervation, particularly BDNF, NGF, and GDNF [8,9,34,35].
As its name suggests, NGF is primarily involved in the growth, as well as the maintenance, proliferation,
and survival of nerve cells, which undergo apoptosis in its absence [36]. It rapidly increases a few
days after a lesion and remains elevated for up to 2 weeks [37] suggesting the increase we observed
was a result of a recent or ongoing changes at the synapse. NGF stimulates cell survival through the
activation of several intracellular pathways, in particular, it leads to the activation of the PI3K-Akt and
MAPK pathways, which both result in transcriptional increased expression of anti-apoptotic proteins.
Consequently, NGF may be a viable target for a therapeutic intervention.
Transcript analysis was performed in whole gastrocnemius muscle from the mice, while changes
occurring at individual NMJ may be mediated locally from the underlying nucleus. It is possible that
this approach masked some of the changes and thus follow up experiments could examine transcripts
from laser dissected NMJs. If this was coupled with immunostaining, then correlations may also be
found with structural changes.
The proteomic signature of SH3TC2-deficient sciatic nerves from Sh3tc2∆Ex1/∆Ex1 animals was
studied to correlate our morphological findings, suggestive of NMJ-vulnerability in the absence of
degenerating demyelinated axons, with changes in abundances of proteins. GFAP has been identified
as a protein with increased abundance in the sciatic nerves of the CMT4C mouse model and increases
of this protein has already been described in the aetiology of other neuropathies [38] and is important
for nerve regeneration [39]. In addition, the increase of FIBB, FIBG and MFAP2 might indicate a
compensatory mechanism towards prevention of axonal degeneration as fibrin gel conduits improve
re-myelination, axon ingrowth and innervation in a nerve-regeneration model [40]. As OLFL3 is
important for functional organization of the nervous system [41], its increase in SH3TC2-deficient
nerves also accords with activation of neuronal pro-survival mechanisms. This concept is further
supported by the observed increase of NGF transcript level (see above) concomitant with TGM2, two
proteins working in concert in cytoprotection and neurite outgrowth [42], as well as by an increase of
APOD [43], APOE [44], SYNPO [45], and RABP2 [46]. The possible protective role on the axon of these
sciatic nerve proteins could be investigated further through their targeting in cell and animal models
that demonstrate axonal degeneration in response to de-myelination.
Regarding the vulnerability of NMJs to the loss of SH3TC2, increases of five different collagens
suggest the activation of molecular mechanisms to prevent the complete breakdown of the NMJ.
These proteins have been linked to structural and functional integrity as well as regeneration of
the NMJ [47,48]. Moreover, collagens promote acetylcholine receptor clustering [49] and transcripts
encoding for the gamma-subunit of the AChR were increased in gastrocnemius muscle of diseased
animals (see above). C1QB is also increased in sciatic nerves derived from Sh3tc2∆Ex1/∆Ex1 mice and
complement activation at the motor end-plates in amyotrophic lateral sclerosis has been described as a
disease modifier [50]. Since homozygous LAMA5 mutations have been linked to a pre-synaptic form
of congenital myasthenic syndrome associated with myopia, facial tics, and failure of neuromuscular
transmission [51], increase of this protein in SH3TC2-deficient nerves supports the concept of
prevention of NMJ-breakdown in Sh3tc2∆Ex1/∆Ex1 animals. In the same context, MATN2 (also
increased in SH3TC2-deficient nerves) modulates axon guidance [52] and may, therefore, contribute
to the observed increase in nerve branches in gastrocnemius muscles of Sh3tc2∆Ex1/∆Ex1 animals [53].
The pathomorphological observation that these increased branches are shortened might correlate with
the decrease of IF5A2 (www.uniprot.org/uniprot/Q8BGY2, accessed on 9 October 2018).
We have demonstrated at the structural, transcriptional, and protein level, that Sh3tc2∆Ex1/∆Ex1
mice undergo synaptic vulnerability that may contribute to the pathogenic mechanisms of the disease
while axons seem to be preserved. Our data provide basis for the further characterization of NMJ
changes in CMT4C patients and indicate that Sh3tc2∆Ex1/∆Ex1 mice represent a relevant model to
evaluate potential therapeutic approaches aiming at preserving the synapses between moto neuron
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axons and muscles. It would be interesting to further explore these NMJ changes by treatment of
the mice with anticholinesterase drugs, to see if this modifies the NMJ alterations observed here.
If performed in humans harboring the CMT4C mutations it could also ascertain if NMJ changes are
present in patients and if they represent a viable therapeutic target.
4. Materials and Methods
4.1. Materials Animals
Mice were housed with 12-h light/dark cycles and had access to water and standard chow ad
libitum. Genotyping was performed as previously described [8]. All animal work was performed
in accordance with the Swedish regulations and approved by the regional ethics review committee
Stockholm, Stockholms norra djurförsöksetiska nämnd (number N79/15, approved 29 September
2015). Mice were sacrificed after anesthetic overexposure by cervical dislocation.
4.2. NMJ Structural Analysis Using Whole Mount Muscle
NMJ staining was performed using gastrocnemius muscle from eight months-old Sh3tc2∆Ex1/∆Ex1
mice according to standard procedures [23,27]. On the day of collection muscles were fixed overnight
in 4% paraformaldehyde, then washed twice in phosphate buffered saline (PBS) and stored in PBS
until labelling. To label the NMJs, muscles were first separated into small fiber bundles (5–10 fibers)
under a stereomicroscope. Samples were permeabilized in ethanol and methanol for 10 min (−20 ◦C).
Samples were incubated in blocking solution (5% horse serum, 5% Bovine Serum Albumin (BSA), 1%
Triton X-100 in PBS) for 4 h at room temperature (RT) with gentle agitation. Muscles were incubated
with primary antibodies overnight (4 ◦C) on a rocking table, all diluted in blocking solution without
triton X-100 (Rb pAB to Synaptophysin (Abcam, Cambridge, UK, 1:100 dilution) and Mouse mAb
to Neurofilament (Cell Signalling, Danvers, MA, USA, 1:100 dilution)). The following day, samples
were incubated for a further 2 h (RT) and washed 4 × 1 h in blocking solution. Samples were then
incubated overnight in the dark (4 ◦C) with secondary antibodies (Alexa Fluor 594 Goat anti-Rabbit
Immunoglobin (IgG) (Thermo Fisher Scientific, Waltham, MA, USA, 1:200 dilution) and Alexa Fluor
594 Goat anti-mouse IgG1 (Thermo Fisher Scientific, 1:200 dilution)), together with Alexa Fluor
488-conjugated α-bungarotoxin (1:250). Finally, the muscles were washed 4 × 1 h in PBS and mounted
on slides using Vectashield Hard Set™ medium for fluorescence (Vector Laboratories, Burlington,
CA, USA) and covered with a cover slip. Imaging was performed using a Nikon eclipse-T Inverted
Confocal Microscope (Nikon, Tokyo, Japan) (512 × 512 frame size, ×60 magnification, 2 µm z-stack
interval, and sequential image acquisition). All NMJs visible in the sample were imaged, with an
average of 42 ± 9 (mean ± SEM) NMJs being analysed per sample. Analysis was performed on
maximum intensity projections according to a recently published protocol [27] using Image J/Fiji
(ImageJ 1.51 K, Java 1.6.0_24, NIH, Bethesda, MD, USA) [33].
4.3. Gene Expression Studies
To try and determine the events preceding any changes in NMJ structure gene expression studies
were performed on gastrocnemius muscle from 4 control and 4 Sh3tc2∆Ex1/∆Ex1 mice at six months
of age.
4.4. RNA Extraction and Conversion
RNA isolation was performed using a standard phenol-chloroform protocol. The tissue was
weighed and one volume of trizol was added and the samples homogenised on ice using a Tissue
Ruptor (QIAGEN Instruments Venio, The Netherlands). Samples were incubated for 5 min (RT) and
centrifuged (4 ◦C) for 10 min at 12,000× g. Next, 0.2 mL of chloroform/volume of trizol was added to
the cleared homogenate solution and the sample vigorously shaken by hand for 15 s. Samples were
then incubated for 2–3 min (RT) and centrifuged at 12,000× g for 15 min (4 ◦C). The aqueous phase
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containing the RNA was transferred into a fresh tube. Then 0.5 mL/volume of trizol of isopropyl
alcohol was added to each sample which was shaken by hand and incubated for 10 min (RT). Samples
were centrifuged at 12,000× g for 15 min (4 ◦C) to obtain a pellet containing RNA which was washed
in 75% ethanol and centrifuged at 12,000× g for 5 min (4 ◦C). The pellet was dried in a heat block
(55–60 ◦C), dissolved in RNase-free water and incubated for 10 min. Samples were assessed for purity
and concentration using a Thermo Fisher Scientific Nanodrop 2000 and then underwent treatment
for DNA removal using the Ambion Life tech DNA-Free Kit™ (Thermo Fisher Scientific, Waltham,
MA, USA). Reverse Transcription was performed using the Applied Biosystems High Capacity cDNA
Reverse Transcription kit (Thermo Fisher Scientific. A master mix composed of: 10× RT Buffer, 25×
dNTPs Mix, 10× RT Random Primers, MultiScribe RT and Nuclease-free H2O was prepared. 10 µL
of master mix was mixed with 10 µL of RNA. Samples were briefly centrifuged and placed onto a
thermal cycler using the following protocol: 10 min at 25 ◦C, 120 min at 37.5 ◦C, 5 min at 85 ◦C, and at
4 ◦C until use.
4.5. Real-Time PCR (qPCR)
To determine the optimum conditions for the qPCR reaction a “pooled” cDNA sample containing
2 µL of each sample was made and used to determine the primer annealing temperature, cDNA
dilution, and efficiency of the reaction (Supplementary Table S1). Tata Box Binding protein was chosen
as reference gene as it has been shown to be one of the most stable genes in myogenic cells [54–56].
The qPCR reaction was performed using Power SYBR® Green PCR Master Mix (Thermo Fisher Scientific)
with 2 µL of diluted cDNA and 18 µL of master mix composed of 6 µL of DEPC-H2O, 1 µL of forward
primer, 1 µL of reverse primer (Supplementary Table S1) and 10 µL of SYBR Green. Samples and
no-template control (NTC) were run in triplicate. Experiments were performed on a BIO-RAD CFX
machine (Bio-Rad Laboratories, Berkeley, CA, USA) under the following conditions: 40 cycles (95 ◦C
for 10 min, 95 ◦C for 15 s, primer annealing temperature for 30 s), with a melt curve performed at the
end to check for contamination and primer dimer (65 ◦C to 95 ◦C with increment of 0.5 ◦C for 5 s).
Samples were only included if the melt curve gave a single clear peak, the sample triplicates were
consistent, and the cycle threshold CT values were at least 3 CT from the NTC. Data was analysed using
the ∆∆Cq method.
4.6. Sample Preparation for Proteomics
Nerve tissues derived from eight-month-old Sh3tc2∆Ex1/∆Ex1 and control (heterozygous) mice
were snap-frozen in liquid nitrogen, followed by homogenization in 0.3 mL lysis buffer composed of
50 mM Tris-HCl (pH 7.8), 150 mM NaCl and 1 % sodium dodecyl sulfate (SDS), supplemented with
complete mini EDTA-free and phosphoStop (Roche, Basel, Switzerland). After sonication three times
with 4 s pulses for 20 s and incubation on ice for 30 min, a centrifugation at 16,000× g for 30 min (4 ◦C)
was performed and the supernatant containing the extracted proteins was collected. A BCA assay
was performed to determine protein concentration of the supernatant (Pierce BCA Protein Assay Kit,
Thermo Fisher Scientific). Afterwards proteins underwent reduction with dithiothreitol (F.c 10 mM
DTT) at 56 ◦C for 30 min and carbamidomethylation with iodoacetamide (F.c. 30 mM IAA) for 30 min
in the dark. Next, 100 µg of proteins were subjected to the filter-aided sample preparation (FASP)
using 30 kDa weight cut-off (MWCO) membrane filter (Pall Corporation, Nanosep, Post Washington,
New York, NY, USA)) and 100 µL of 8 M Urea in Tris-HCl buffer (pH 8.5). Centrifugation for three
times at 13,500× g at RT was applied to wash the proteins in the filter. Afterwards, three washing steps
with 50 mM aminobicarbonate (NH4HCO3) buffer (pH 7.8) were performed in the same manner as
with urea buffer. Lastly, proteins were subjected into 100 µL tryptic digestion buffer of 4 µg trypsin
(Promega, Trypsin Gold, Mass Spectrometry Grade, Madison, WI, USA) in 2 mM CaCl2, 0.2 GuHCl
and 50 mM ABC (pH 7.8) for 14 h at 37 ◦C. Next day, the tryptic peptides were collected using
centrifugation for 13,500× g for 15 min, together with 50 µL of 50 mM ABC buffer (pH 7.8) and then
with 50 µL of ultra-pure H2O. Subsequently, an acidification step with 10 % TFA (v/v) to completely
Int. J. Mol. Sci. 2018, 19, 4072 15 of 20
inactivate trypsin was introduced to the tryptic mixture and peptides were stored at 4 ◦C or −20 ◦C
for short-term usage. The digestion efficiency was controlled by reversed-phase chromatography on
an Ultimate 3000 (Thermo Fisher Sccientific) equipped with a PepSwift Monolithic Rapis Seperation
Liquid Chromatography(RSLC), 200 µm × 5 cm, column.
4.7. Nano LC-ddMS/MS Analysis and Label-free Protein Quantitation
LC-ddMS/MS analysis was performed on an Ultimate U3000 nano RSLC system coupled to an
Orbitrap Fusion™ Lumos™ Tribrid™ Mass Spectrometer (Thermo Fisher Scientific). First, tryptic
peptides were pre-concentrated on an Acclaim PepMap 100 µm × 2 cm, C18, 5 µm, 100 Å trap column
using 0.1% TFA (v/v) for 10 min, at a flow rate of 20 µL/min. Next, peptide separation on an Acclaim
PepMap RSLC 75 µm× 50 cm, C18, 2 µm, 100 Å main column using a linear gradient from 97% solvent
A (0.1% formic acid) and 3% solvent B (84% acetonitrile in 0.1% formic acid) to 35% solvent B over
120 min at a flow rate of 250 nL/min. The ddMS/MS data acquisition was set to obtain MS scan in the
orbitrap from 300 to 1500 m/z at a resolution of 120,000, polysiloxane ion at 445.12002 m/z was used as
lock mass. The most intense ions were then subjected to high collision induced dissociation (HCD),
MS/MS scans were detected in the linear ion trap. The ion accumulation time was set to 300 ms (MS)
and 50 ms (MS/MS). The automatic gain control (AGC) was set to 2 × 106 for MS survey scans and 2
× 104 for MS/MS scans.
Data analysis of the acquired label-free quantitation started with importing MS raw files for three
biological replicates of Sh3tc2∆Ex1/∆Ex1 mice sciatic nerves and three corresponding controls into the
Progenesis Qi LC-MS software from Nonlinear Dynamics (Newcastle upon Tyne, UK). Progenesis Qi
selected one of the LC-MS files as reference to align all the MS raw data. Peak-picking step within
0–120 min retention time, mass to charge ratios of 300–1500 and charge states of +2, +3, or +4 were
selected for peptide statistics. MS/MS spectra exported directly into a mgf file from Progenesis Qi were
subsequently searched against a concatenated target/decoy database of mouse proteome (downloaded
from Uniprot in July 2015 containing 16,716 target sequences). SearchGUI 3.2.20 and Mascot 2.4.0
(Matrix Science) were chosen as search engines with usage of X!Tandem Jackhammer (2015.12.15.2),
MS-GF+ Beta (v10282) (19 Decenmber 2014) algorithms. The search criteria in each engine were set as:
a maximum of two missed cleavages for trypsin, carbamidomethylation of cysteine and oxidation of
methionine as fixed and variable modifications, respectively, 10 ppm and 0.5 Da for MS and MS/MS
tolerances, respectively. PeptideShaker 22 1.16.15 was used for interpretation of identified peptides and
proteins from all search engines (SearchGUI and Mascot) with a false discovery rate (FDR) of 1% on
the protein level. The database search results were then imported back into Progenesis Qi. Afterwards,
proteins that were quantified with unique peptides were exported and the normalized abundances’
average of each protein (obtained from Progenesis) from the triplicate analyses was calculated to
determine the ratios between the CMT4C and control nerve samples.
4.8. Statistical Analysis
All statistical analysis was performed using GraphPad Prism V7, GraphPad, San Diego, CA, USA).
Data was tested for normality using the D’Agostino-Pearson omnibus normality test and outliers
were identified using the ROUT (Q = 1%) method. Normally distributed data were analysed using
students t-test, while non-parametric data was analysed using the Mann-Whitney test, with p < 0.5
being considered significant. The removal of outliers did not affect the statistical tests in terms of
significance levels and thus all data points are included in the graphs unless otherwise stated. All data
and graphs show mean ± standard error of mean (SEM), with control animal values being given first
followed by Sh3tc2∆Ex1/∆Ex1 animals. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
5. Conclusions
In conclusion, a murine model for the human disease CMT4C, the Sh3tc2∆Ex1/∆Ex1 mouse, shows
NMJ alterations on a structural and transcriptional level, supported by proteome findings in the sciatic
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nerve, that could contribute to the pathomechanisms of the disease. The increase in branching at the
NMJ of Sh3tc2∆Ex1/∆Ex1 mice may be an attempt at adapting to the pathology and is probably mediated
by an increase in neurotrophic factors produced by muscle and proteomic changes in the sciatic
nerve. If NMJ vulnerability is demonstrated in patients then it extends the list of neurodegenerative
conditions in which the NMJ is a site of pathology and may offer a potential therapeutic target.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/19/12/
4072/s1 and include a table of primer sequences and reaction conditions.
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Abbreviations
CMT Charcot-Marie Tooth
SH3TC2 SH3 domain and tetratricopeptide repeats 2
Nrg1/ErbB Neuregulin-1/ErbB
NMJ Neuromuscular junction
tSC Terminal Schwann cells
SEM Standard Error of the Mean
AChRγ/α/ε Acetylcholine Receptor gamma/alpha/epsilon
MuSK Muscle Specific Kinase
NCAM Neural cell adhesion molecule
NGF Nerve growth factor
BDNF Brain-derived neurotrophic factor
CNTF Cilliary neurotrophic factor
GDNF Glial cell derived neurotrophic factor
NTRK Neurotrophic receptor tyrosine kinase
ECM Extra-cellular matrix
MAPK Mitogen activated protein kinases
GFAP Glial fibrillary acidic protein
THRSP Thyroid Hormone-Responsive
FIBB Fibrinogen beta chain
FIBG Fibrinogen gamma chain
MFAP2 Microfibrillar-associated protein 2
OLFL3 Olfactomedin-like protein 3
TGM2 Protein-glutamine gamma-glutamyltransferase 2
RABP2 Cellular retinoic acid-binding protein 2
C1QB Complement C1q subcomponent subunit B
LAMA Laminin subunit alpha
APOD/E Apolipoprotein D/E
MATN2 Matrilin-2
SYNPO Synaptopodin
pAB/mAB Poly/mono-clonal antibody
IgG Immunoglobulin g
PBS Phosphate Buffered Saline
Int. J. Mol. Sci. 2018, 19, 4072 17 of 20
NTC No template Control
RT Room Temperature
CT Cycle Threshold
BCA bicinchoninic acid assay
MS Mass spectrometry
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